相关实验视频

Updated: Jan 11, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

在患有勒维体痴呆症的患者中,视觉幻觉和α-synuclein oligomers之间存在关联

Hiroaki Sekiya¹, Lukas Franke¹, Daisuke Ono¹

¹Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|November 14, 2025

概括

而非勒维体的α-synuclein (αSYN) 寡合体与勒维体痴呆症 (DLB) 中的视觉幻觉 (VHs) 有关. 这表明αSYN寡合体可能是DLB患者VH的治疗点.

科学领域:

神经科学是一个神经科学.
神经病理学神经病理学
痴呆症研究痴呆症研究

背景情况:

视觉幻觉 (VHs) 是莱维体痴呆症 (DLB) 的一个关键症状.
在DLB中VHs的确切病理原因尚未完全理解.
调查alpha-synuclein (αSYN) 病理在VHs中的作用至关重要.

研究的目的:

调查αSYN寡合体与DLB中VHs的Lewy相关病理之间的关联.
为了比较DLB患者与没有VHs的视觉通路的大脑区域中的αSYN寡合体负担.
确定DLB中VH的潜在神经病理点.

主要方法:

使用了近距离结合试验 (PLA) 和酸化αSYN免疫组织化学.
在腹部视觉通路中量化了αSYN寡合体和与Lewy相关的病理.
分析了DLB患者和没有VH的脑组织.

主要成果:

在VHs的DLB患者的副海马皮层中发现了αSYN寡合体的显著较高负担.
与常规的莱维病理相关的负担在DLB患者和没有VHs之间是相似的.
这项研究提供了第一个人类大脑证据,将αSYN寡合物与DLB中的VH联系起来.

结论:

αSYN寡合体,而不是与Lewy相关的病理,在DLB中与VH更强烈相关.
这些发现突出了αSYN寡合体作为在DLB中管理VH的潜在治疗点.
向αSYN寡合体可能为治疗DLB中的VH提供一种新的策略.

关键词:

患有利维体痴呆症的痴呆症一些小分子.视觉幻觉 - 视觉幻觉是一种幻觉.α-synuclein 是一种同核蛋白.

更多相关视频

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...